← Research / Adaptogens

Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study

RCTAdaptogensHigh confidence
Read full paper →
AuthorsGopukumar Kumarpillai, Shefali Thanawala, Somepalli Venkateswarlu, Tejas Rao, Vijaya Bhaskar Thamatam, Sanjaya Chauhan
JournalEvidence-based Complementary and Alternative Medicine
Year2021
DOI10.1155/2021/8254344
Citations88

Abstract

Background. The global prevalence of stress is increasing. Stress adversely affects cognitive ability, sleep quality, and overall psychological well-being. Ashwagandha (Withania somnifera (L.) Dunal), an essential medicine in Ayurveda, is reportedly beneficial in reducing stress and improving memory. This double-blind, randomized, placebo-controlled clinical study evaluated the effect of Ashwagandha root extract sustained-release capsule 300 mg (Prolanza™; hereafter Ashwagandha SR) on cognitive functions, stress levels, sleep quality, overall well-being, and safety in stressed subjects. Methods. Subjects (130 healthy cognitively sound adults [20–55 years, body mass index:18–29 kg/m2]) having a Perceived Stress Scale (PSS) score of 14–24 were randomized to receive either Ashwagandha SR or placebo. Subjects took one capsule of Ashwagandha SR or placebo daily for 90 consecutive days. This study was registered on Clinical Trials Registry-India (CTRI) on 13/11/2019 [number: CTRI/2019/11/021990]. The primary endpoint was the change in cognitive function as measured by CANTAB from baseline to the end of the study period (90 ± 7 days). The secondary outcomes included the change in PSS-10 score, serum cortisol level (9–11 am), the OHQ score, the PSQI, and serum BDNF levels. Results. Only 125 completed the study and were evaluated. The Cambridge Neuropsychological Test Automated Battery (CANTAB) reported significantly improved recall memory, and the total error rate in recalling patterns significantly decreased at visit 4 in the Ashwagandha SR group vs. the placebo group (first attempt memory score:12.9 ± 6.7 vs. 10.1 ± 6.3; total errors:17.5 ± 23.3 vs. 27.7 ± 23.6). At visit 4, lower PSS-10 score (13.0 ± 5.0 vs. 18.7 ± 4.6; <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>p</a:mi> <a:mo>&lt;</a:mo> <a:mn>.0001</a:mn> </a:math> ), serum cortisol levels <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mfenced open="(" close=")" separators="|"> <c:mrow> <c:mi>p</c:mi> <c:mo>=</c:mo> <c:mn>0.0443</c:mn> </c:mrow> </c:mfenced> </c:math> , and Pittsburgh Sleep Quality Index (PSQI) score <h:math xmlns:h="http://www.w3.org/1998/Math/MathML" id="M3"> <h:mfenced open="(" close=")" separators="|"> <h:mrow> <h:mi>p</h:mi> <h:mo>&lt;</h:mo> <h:mn>.0001</h:mn> </h:mrow> </h:mfenced> </h:math> but higher Oxford Happiness Questionnaire (OHQ) scores <m:math xmlns:m="http://www.w3.org/1998/Math/MathML" id="M4"> <m:mfenced open="(" close=")" separators="|"> <m:mrow> <m:mi>p</m:mi> <m:mo>&lt;</m:mo> <m:mn>.0001</m:mn> </m:mrow> </m:mfenced> </m:math> were seen in Ashwagandha SR vs. the placebo group, suggesting significantly lower stress levels and significantly better psychological well-being and sleep quality in the former. No adverse events were reported. Conclusions. This is the first clinical study assessing Ashwagandha SR for its safety and efficacy. Treatment with one Ashwagandha SR capsule once daily for 90 days improved memory and focus, psychological well-being, and sleep quality, reduced stress levels, and was safe and well-tolerated.

Read full paper →More Adaptogens

Related papers

RCT

An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract

Adrian L. Lopresti, Stephen J. Smith, Hakeemudin Malvi +1 more · 2019

Meta-analysis

Targeting metabolic disorders by natural products

Ozra Tabatabaei‐Malazy, Bagher Larijani, Mohammad Abdollahı · 2015

RCT

A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost®) on mood and cognition in healthy young adults, including in vitro investigation of gut microbiota changes as a possible mechanism of action

Lynne Bell, Adrian R. Whyte, Cindy Duysburgh +6 more · 2021

RCT

The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report

Alka Mishra, Sumitra A. Bentur, Sonika Thakral +2 more · 2021